| Page 143 | Kisaco Research

• Identify risk areas in chargemaster (CDM) pricing that are often overlooked.
• Describe ways to rationalize and defend pricing.
• Effectuate processes to stay current with price transparency regulations.

Revenue Cycle Management

Author:

Sarah L. Goodman

President.CEO
SLG, Inc.

Sarah L. Goodman

President.CEO
SLG, Inc.
 

Sarah L. Goodman

President.CEO
SLG, Inc.

Sarah L. Goodman

President.CEO
SLG, Inc.

Sarah L. Goodman

President.CEO
SLG, Inc.
Economic Crime Prevention DACH Summit - Agenda
 

Todd Zion

CEO and Chairman
Akston Biosciences

Todd Zion

CEO and Chairman
Akston Biosciences

Todd Zion

CEO and Chairman
Akston Biosciences
 

Paul Higgs

Chief Veterinary Officer and Internal Medicine Specialist
CVS Vets

Paul Higgs

Chief Veterinary Officer and Internal Medicine Specialist
CVS Vets

Paul Higgs

Chief Veterinary Officer and Internal Medicine Specialist
CVS Vets
 

Eric Morgen

Co-Founder & COO
BioAge Labs

Eric Morgen

Co-Founder & COO
BioAge Labs

Eric Morgen

Co-Founder & COO
BioAge Labs
 

Dr. Mathias Zadrazil

Chief Compliance Officer EMEA
Zimmer Biomet

Dr. Mathias Zadrazil is Chief Compliance Officer EMEA at Zimmer Biomet in Zug since September 2023. Prior to that, he worked as General Counsel Legal & Compliance International at the US medtech company Cardinal Health. Professional career: Vice President Pharma Law at Novo Nordisk in Copenhagen, before that General Counsel L&C Europe at Novo Nordisk in Zurich. His in-house career started as Legal Counsel in Novartis Pharma AG in Basel; Before that, he was a lawyer at Vischer law firm.

Dr. Mathias Zadrazil

Chief Compliance Officer EMEA
Zimmer Biomet

Dr. Mathias Zadrazil

Chief Compliance Officer EMEA
Zimmer Biomet

Dr. Mathias Zadrazil is Chief Compliance Officer EMEA at Zimmer Biomet in Zug since September 2023. Prior to that, he worked as General Counsel Legal & Compliance International at the US medtech company Cardinal Health. Professional career: Vice President Pharma Law at Novo Nordisk in Copenhagen, before that General Counsel L&C Europe at Novo Nordisk in Zurich. His in-house career started as Legal Counsel in Novartis Pharma AG in Basel; Before that, he was a lawyer at Vischer law firm. Mathias studied at the University of Freiburg (DE), received his doctorate from the University of Lausanne, obtained an LL.M. in Montreal and is admitted to the bar in Switzerland and Germany.